Corrigendum to "ONCOPOOL - A European database for 16,944 cases of breast cancer" [European Journal of Cancer 46 (2009) 56-71] (DOI:10.1016/j.ejca.2009.09.009);ONCOPOOL - A European database for 16,944 cases of breast cancer

European Journal of Cancer

Volumn 46, Issue 1, 2010, Pages 56-71

  Blamey, R W ^a   Hornmark Stenstam, B ^a   Ball, G ^a   Blichert Toft, M ^a   Cataliotti, L ^a   Fourquet, A ^a   Gee, J ^a   Holli, K ^a   Jakesz, R ^a   Kerin, M ^a   Mansel, R ^a   Nicholson, R ^a   Pienkowski, T ^a   Pinder, S ^a   Sundquist, M ^a   van de Vijver, M ^a   Ellis, I ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Endocrine receptors; European database; Prognostic factors; Prognostic index; Survival; Tumour pathology

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CAUSE OF DEATH; DATA BASE; EUROPE; HORMONAL THERAPY; HUMAN; LYMPH NODE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK REDUCTION; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 71049127875     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.03.004     Document Type: Erratum

References (20)

1. Henson D.E., Reis L., Freedman L.S., and Carriaga M. Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer 68 (1991) 2142-2149
2. Ries L.A.G.R., Henson D.E., and Harras A. Survival from breast cancer according to tumor size and nodal status. Surg Oncol Clin North Am 3 (1994) 35-53
3. Beral V., Hermon C., Reeves G., and Peto R. Sudden fall in breast cancer death rates in England and Wales. Lancet 345 (1995) 1642-1643
4. Haybittle J.L., Blamey R.W., Elston C.W., et al. A prognostic index in primary breast cancer. Br J Cancer 45 (1982) 361-366
5. Galea M.H., Blamey R.W., Elston C.W., and Ellis I.O. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22 (1992) 207-219
6. Blamey R.W., Ellis I.O., Pinder S.E., et al. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer 43 (2007) 1548-1555
7. Blamey R.W., Pinder S.E., Ball G.R., et al. Reading the prognosis of the individual with breast cancer. Eur J Cancer 43 (2007) 1545-1547
8. Elston C.W., and Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long term follow-up. Histopathology 19 (1991) 403-410
9. Macmillan R.D., Barbera D., Hadjiminas D.J., et al. Sentinel node biopsy for breast cancer may have little to offer four-node samplers: results of comparison study. EJC 37 (2001) 1076-1080
10. Weigelt B., Hu Z., He X., et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res 65 20 (2005) 9155-9158
11. Pereira H., Pinder S.E., Sibbering D.M., et al. Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 27 (1995) 219-226
12. Diab S.G., Clark G.M., Osborne C.K., et al. Tumour characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol 17 (1999) 1442-1448
13. Balslev I., Axelsson C.K., Zedeler K., et al. The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat 32 3 (1994) 1837-1841
14. Ries LAG, Young JL, Keel GE, et al., editors. SEER survival monograph: cancer survival among adults: U.S. SEER Program, 1988-2001, patient and tumor characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD; 2007.
15. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998; 351:1451-67.
16. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 1998; 352:930-42.
17. Maynard P.V., Griffiths K., Davies C.J., Elston C.W., and Blamey R.W. The relationships between oestrogen receptor content, histological grade in human primary breast tumours. Br J Cancer 38 (1978) 745
18. D'Eredita G., Martellotta M., Natale T., and Ferrarese F. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long term follow-up and treated in a single institution. Eur J Cancer 37 (2001) 591-596
19. Lundin J. The Nottingham Prognostic Index - from relative to absolute risk prediction. Eur J Cancer 43 (2007) 1498-1500 [editorial comment]
20. Joensuu H., Lehtimöki T., Holli K., et al. Risk of distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 292 9 (2004) 1967-1973